Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Taiwan
/
Stocks
/
Health Technology
/
Biotechnology
/
6586
/
Financials
6
6
6
CHO PHARMA INC
6586
Taipei Exchange
6586
Taipei Exchange
6586
Taipei Exchange
6586
Taipei Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Financials
Discussions
Technicals
Seasonals
6586 fundamentals
Overview
Statements
Statistics
Dividends
Earnings
Revenue
More
CHO PHARMA INC financial statements, including revenue, expenses, profit, and loss
The annual and semiannual earnings report below will help you understand the performance of 6586.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Income statement
Balance sheet
Cash flow
Annual
Annual
Quarterly
Quarterly
Currency: TWD
TTM
Total revenue
YoY growth
—
—
—
—
—
—
—
—
Cost of goods sold
—
—
—
—
—
—
—
—
Gross profit
YoY growth
—
—
—
—
—
—
—
—
Operating expenses (excl. COGS)
—
—
—
—
—
—
—
—
Operating income
YoY growth
—
—
—
—
—
—
—
—
Non-operating income, total
—
—
—
—
—
—
—
—
Pretax income
YoY growth
—
—
—
—
—
—
—
—
Equity in earnings
—
—
—
—
—
—
—
—
Taxes
—
—
—
—
—
—
—
—
Non-controlling/minority interest
—
—
—
—
—
—
—
—
After tax other income/expense
—
—
—
—
—
—
—
—
Net income before discontinued operations
—
—
—
—
—
—
—
—
Discontinued operations
—
—
—
—
—
—
—
—
Net income
YoY growth
—
—
—
—
—
—
—
—
Dilution adjustment
—
—
—
—
—
—
—
—
Preferred dividends
—
—
—
—
—
—
—
—
Diluted net income available to common stockholders
—
—
—
—
—
—
—
—
Basic earnings per share (Basic EPS)
YoY growth
—
—
—
—
—
—
—
—
Diluted earnings per share (Diluted EPS)
YoY growth
—
—
—
—
—
—
—
—
Average basic shares outstanding
—
—
—
—
—
—
—
—
Diluted shares outstanding
—
—
—
—
—
—
—
—
EBITDA
YoY growth
—
—
—
—
—
—
—
—
EBIT
YoY growth
—
—
—
—
—
—
—
—
Total operating expenses
—
—
—
—
—
—
—
—